Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhEPO-Fc vs EPO (CHO) in hemodialysis CKD anemia maintenance
CTR20210357Phase 3Completed
- Sponsor
- Shanghai Meiye Biotechnology
- Start
- Mar 2021
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of rhEPO-Fc in anaemia, sponsored by Shanghai Meiye Biotechnology. Started Mar 2021; status: completed.
02
Drugs
rhEPO-Fc
03
Conditions
anaemia
Beyond the preview
Go deeper on CTR20210357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210357.